| http://www.w3.org/ns/prov#value | - Identification and validation of surrogate markers in bio-fluids (e.g. plasma, serum, urine, bile, pancreatic and gastrointestinal fluids) or tissues that correlate with stage, activity or rate of progression, or complications of diseases, including diabetes and chronic liver diseases, such as viral hepatitis.
|
